Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
BNC Korea (256840 KS)
Watchlist
27
Analysis
Health Care
•
South Korea
BNC Korea Co, Ltd operates as a biological development company. The Company develops, manufactures and sells hyaluronic acid filler and other products. BNC Korea markets its products throughout Korea.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
BNC Korea
•
08 Apr 2022 18:33
BNC Korea (256840 KS): Late Mover in COVID Pill; 2021 Operating Loss and Russia Exposure Add to Woe
I am still bearish on the company as its partnered COVID-19 pill will be a late entrant in the market. Moreover, its huge dependence on Russia for...
Tina Banerjee
Follow
593 Views
Share
bearish
•
PI Advanced Materials
•
09 Dec 2021 03:19
Short Position Approach on the Index Entrants on December 10 in Korea
The effective date for rebalancing KOSPI 200 and KOSDAQ 150 is this Friday, meaning that this is the first trading day that short selling is...
Sanghyun Park
Follow
491 Views
Share
bullish
•
SK Materials
•
25 Nov 2021 08:55
15 Adds & 15 Deletes in KOSDAQ 150 Rebalancing: Passive Impact & Trade Approaches
The KOSDAQ 150 December rebalancing features a total of 15 additions and 15 deletions. This post details the results as well as the passive impact...
Sanghyun Park
Follow
478 Views
Share
bullish
•
Coocon Corp
•
24 Nov 2021 20:11
KOSDAQ150 Index Rebalance: Pullback Done; Buy Adds & Sell Deletes
There are 15 changes for the KOSDAQ150 index in December. The impact on the deletions is larger than that on the inclusions. A long adds/short...
Brian Freitas
Follow
602 Views
Share
bullish
•
M2N Co.,Ltd
•
02 Nov 2021 13:43
KOSDAQ150 Index Rebalance Preview: 15 Potential Changes and Large Turnover
At the end of the review period, we see 15 potential changes for the KOSDAQ150 index. Most of the changes are high probability. The adds could...
Brian Freitas
Follow
888 Views
Share
First
Previous
1
2
3
4
5
6
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x